Your browser doesn't support javascript.
loading
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Connor, Matthew P; Loren, Alison W; Hexner, Elizabeth O; Martin, Mary Ellen; Gill, Saar I; Luger, Selina M; Mangan, James K; Perl, Alexander E; McCurdy, Shannon R; Pratz, Keith W; Timlin, Colleen; Freyer, Craig W; Carulli, Alison; Catania, Christopher; Smith, Jacqueline; Hollander, Lauren; Zebrowski, Alexis M; Stadtmauer, Edward A; Porter, David L; Frey, Noelle V.
  • Connor MP; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: matthew.connor@pennmedicine.upenn.edu.
  • Loren AW; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hexner EO; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Martin ME; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gill SI; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Luger SM; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Mangan JK; Moores Cancer Center at the University of California, San Diego, California.
  • Perl AE; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • McCurdy SR; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Pratz KW; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Timlin C; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Freyer CW; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Carulli A; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Catania C; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Smith J; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hollander L; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zebrowski AM; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Stadtmauer EA; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Porter DL; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Frey NV; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Transplant Cell Ther ; 29(2): 113-118, 2023 02.
Article en En | MEDLINE | ID: mdl-36336258
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2023 Tipo del documento: Article